Globus Medical executive exercises 34,375 stock options

Globus Medical's executive chairman, who is also a director and 10% owner, reported exercising stock options for 34,375 shares of Class A common stock at $25.52 per share on 12/08/2025.

Rhea-AI Filing Summary

Globus Medical's executive chairman, who is also a director and 10% owner, reported exercising stock options for 34,375 shares of Class A common stock at $25.52 per share on 12/08/2025. Following this option exercise, he directly owns 60,417 shares of Globus Medical Class A common stock.

The derivative position was a stock option giving the right to buy 34,375 Class A shares at an exercise price of $25.52. These options were originally granted on January 25, 2016, are fully vested, and relate to 34,375 underlying Class A shares with an expiration date of 01/25/2026.

Insider Trade Summary

34,375 shares exercised/converted

Exercise 2 txns

Insider Paul David C

Role Executive Chairman

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy Class A Common Stock)	34,375	$0.00	$0.00
Exercise	Class A Common Stock	34,375	$25.52	$877K

Holdings After Transaction: Stock Option (Right to Buy Class A Common Stock) — 0 contracts (Direct); Class A Common Stock — 60,417 shares (Direct)

Footnotes (1)

1. F1. These options were granted on January 25, 2016 and are fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Globus Medical (GMED) report in this Form 4?

The filing reports that the executive chairman of Globus Medical exercised stock options for 34,375 shares of Class A common stock at an exercise price of $25.52 per share on 12/08/2025.

How many Globus Medical (GMED) shares does the insider own after the transaction?

After the reported option exercise, the insider directly holds 60,417 shares of Globus Medical Class A common stock.

What type of derivative security was involved in the Globus Medical (GMED) Form 4?

The derivative security was a stock option (right to buy Class A common stock) covering 34,375 underlying shares with an exercise price of $25.52.

When were the Globus Medical (GMED) stock options originally granted and when do they expire?

The options were granted on January 25, 2016, are fully vested, and carry an expiration date of 01/25/2026.

What is the reporting person’s role and relationship to Globus Medical (GMED)?

The reporting person is listed as a director, 10% owner, and officer of Globus Medical, holding the title of Executive Chairman.

Was this Globus Medical (GMED) Form 4 filed by a single reporting person or a group?

The Form 4 was filed by one reporting person, as indicated by the checked box for individual filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/10/2025 - 04:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Paul David C

(Last) (First) (Middle)

VALLEY FORGE BUSINESS CENTER

2560 GENERAL ARMISTEAD AVENUE

(Street)

AUDUBON PA 19403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/08/2025		M		34,375	A	$25.52	60,417	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)	$25.52	12/08/2025		M			34,375	(1)	01/25/2026	Class A Common Stock	34,375	$0	0	D

Explanation of Responses:

1. These options were granted on January 25, 2016 and are fully vested.

	/s/ Kelly G. Huller, Attorney-in-Fact	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.